ZELREG Trademark

Trademark Overview

On Friday, February 2, 2001, a trademark application was filed for ZELREG with the United States Patent and Trademark Office. The USPTO has given the ZELREG trademark a serial number of 78046198. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Sunday, November 19, 2006. This trademark is owned by Novartis AG. The ZELREG trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of disorders of the central nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, for the treatment of inflammatory disorders, and for use in dermatology, oncology and ophthalmology

General Information

Serial Number78046198
Word MarkZELREG
Filing DateFriday, February 2, 2001
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateSunday, November 19, 2006
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 14, 2002

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of disorders of the central nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, for the treatment of inflammatory disorders, and for use in dermatology, oncology and ophthalmology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 23, 2001
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Tuesday, January 23, 2007ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Tuesday, January 23, 2007ABANDONMENT - NO USE STATEMENT FILED
Friday, May 12, 2006EXTENSION 5 GRANTED
Friday, May 12, 2006EXTENSION 5 FILED
Friday, May 12, 2006TEAS EXTENSION RECEIVED
Thursday, November 17, 2005EXTENSION 4 GRANTED
Thursday, November 17, 2005EXTENSION 4 FILED
Thursday, November 17, 2005TEAS EXTENSION RECEIVED
Tuesday, May 17, 2005EXTENSION 3 GRANTED
Tuesday, May 17, 2005EXTENSION 3 FILED
Tuesday, May 17, 2005TEAS EXTENSION RECEIVED
Tuesday, February 8, 2005APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sunday, December 19, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 6, 2004PAPER RECEIVED
Wednesday, December 1, 2004EXTENSION 2 GRANTED
Monday, November 15, 2004EXTENSION 2 FILED
Monday, November 15, 2004TEAS EXTENSION RECEIVED
Thursday, May 6, 2004EXTENSION 1 GRANTED
Thursday, April 29, 2004EXTENSION 1 FILED
Tuesday, May 4, 2004CASE FILE IN TICRS
Thursday, April 29, 2004TEAS EXTENSION RECEIVED
Tuesday, November 18, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 6, 2003NOTICE OF ALLOWANCE CANCELLED
Wednesday, October 8, 2003EMAIL RECEIVED
Tuesday, September 23, 2003PETITION TO REVIVE-GRANTED
Wednesday, July 9, 2003TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 19, 2003PETITION TO REVIVE-RECEIVED
Thursday, June 19, 2003PAPER RECEIVED
Wednesday, May 21, 2003ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 6, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 14, 2002PUBLISHED FOR OPPOSITION
Wednesday, April 24, 2002NOTICE OF PUBLICATION
Friday, February 15, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 21, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 29, 2001NON-FINAL ACTION MAILED
Thursday, June 28, 2001ASSIGNED TO EXAMINER
Friday, June 15, 2001ASSIGNED TO EXAMINER

Related Keywords

zelreg system disorders treatment inflammatory skeletal musculo oncology ophthalmology respiratory dermatology